TriSalus Life Sciences (TLSI) Amortization of Deferred Charges (2023 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Amortization of Deferred Charges of $31000.0 for Q1 2026, down 82.08% year-over-year from $173000.0 in Q1 2025, and up 3200.0% quarter-over-quarter from -$1000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Amortization of Deferred Charges (2023 - 2026) Analysis & Trends
TriSalus Life Sciences' Amortization of Deferred Charges history runs 4 years deep, the most recent figure standing at $31000.0 for Q1 2026.
- In Q1 2026, Amortization of Deferred Charges fell 82.08% year-over-year to $31000.0; the TTM figure through Mar 2026 stood at $1.4 million (up 8.07% YoY), while the FY2025 annual figure was $766000.0, up 190.15% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $31000.0, up from -$1000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $766000.0 in Q2 2025, with the low at -$130000.0 in Q4 2023.
- The 4-year median for Amortization of Deferred Charges is $130000.0 (2023), against an average of $206230.8.
- The sharpest annual moves came in 2024 and 2025: Amortization of Deferred Charges soared 2254.55% in 2024, then plunged 100.21% in 2025.
- TriSalus Life Sciences' Amortization of Deferred Charges stood at -$130000.0 in 2023, then soared by 473.85% to $486000.0 in 2024, then sank by 100.21% to -$1000.0 in 2025, then soared by 3200.0% to $31000.0 in 2026.
- Business Quant data shows TLSI's Amortization of Deferred Charges at $31000.0 in Q1 2026, -$1000.0 in Q4 2025, and $557000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | TriSalus Life Sciences | 304.89 Mn | 258.60 Mn | 9.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 336,000.00 |
| Jun 30, 2026 | 336,000.00 |
| Mar 31, 2026 | 31,000.00 |
| Mar 31, 2026 | 31,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 557,000.00 |
| Sep 30, 2025 | 557,000.00 |
| Jun 30, 2025 | 766,000.00 |
| Jun 30, 2025 | 766,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Dec 31, 2024 | 486,000.00 |
| Dec 31, 2024 | 486,000.00 |
| Sep 30, 2024 | 356,000.00 |
| Sep 30, 2024 | 356,000.00 |
| Jun 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 237,000.00 |
| Mar 31, 2024 | 76,000.00 |
| Mar 31, 2024 | 76,000.00 |